Aflibercept for Retinopathy of Prematurity - Intravitreal Injection Versus Laser Therapy
NCT04004208
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
113
Enrollment
INDUSTRY
Sponsor class
Conditions
Retinopathy of Prematurity (ROP)
Interventions
DRUG:
Eylea (Aflibercept, BAY86-5321)
PROCEDURE:
Laser photocoagulation
Sponsor
Bayer
Collaborators
[object Object]